These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28078057)
1. The advancements of heparanase in fibrosis. Lv Q; Zeng J; He L Int J Mol Epidemiol Genet; 2016; 7(4):137-140. PubMed ID: 28078057 [TBL] [Abstract][Full Text] [Related]
2. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents. Jia L; Ma S Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of heparanase inhibitors in cancer therapy. Heyman B; Yang Y Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132 [TBL] [Abstract][Full Text] [Related]
5. Heparanase multiple effects in cancer. Nadir Y; Brenner B Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152 [TBL] [Abstract][Full Text] [Related]
6. Heparanase, tissue factor, and cancer. Nadir Y; Vlodavsky I; Brenner B Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924 [TBL] [Abstract][Full Text] [Related]
7. New Advances of Heparanase and Heparanase-2 in Human Diseases. Jin H; Cui M Arch Med Res; 2018 Oct; 49(7):423-429. PubMed ID: 30850186 [TBL] [Abstract][Full Text] [Related]
8. Heparanase procoagulant activity in cancer progression. Nadir Y; Brenner B Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977 [TBL] [Abstract][Full Text] [Related]
9. Heparanase: Historical Aspects and Future Perspectives. Khanna M; Parish CR Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707 [TBL] [Abstract][Full Text] [Related]
10. Development of heparanase inhibitors for anti-cancer therapy. Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340 [TBL] [Abstract][Full Text] [Related]
11. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. Savion N; Disatnik MH; Nevo Z J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131 [TBL] [Abstract][Full Text] [Related]
12. Impact of heparanase on renal fibrosis. Masola V; Zaza G; Onisto M; Lupo A; Gambaro G J Transl Med; 2015 Jun; 13():181. PubMed ID: 26040666 [TBL] [Abstract][Full Text] [Related]
13. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases. Rivara S; Milazzo FM; Giannini G Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774 [TBL] [Abstract][Full Text] [Related]
14. Impact of Heparanse on Organ Fibrosis. Masola V; Gambaro G; Onisto M Adv Exp Med Biol; 2020; 1221():669-684. PubMed ID: 32274731 [TBL] [Abstract][Full Text] [Related]
15. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157 [TBL] [Abstract][Full Text] [Related]
16. Heparanase procoagulant effects and inhibition by heparins. Nadir Y; Brenner B Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010 [TBL] [Abstract][Full Text] [Related]
17. Implications of heparan sulfate and heparanase in neuroinflammation. Zhang X; Wang B; Li JP Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134 [TBL] [Abstract][Full Text] [Related]
18. The Good and Bad Sides of Heparanase-1 and Heparanase-2. Pinhal MAS; Melo CM; Nader HB Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740 [TBL] [Abstract][Full Text] [Related]
19. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate. Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189 [TBL] [Abstract][Full Text] [Related]
20. Heparanase coagulation and cancer progression. Nadir Y; Brenner B Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]